On Aug 31, 2021 Versanis Bio closed a Series A round and raised $70,000,000 from Aditum Bio, Atlas Venture, Medicxi Ventures, featuring lead investors Atlas […]
Series C – TISSIUM
On Aug 31, 2021 TISSIUM closed a Series C round and raised €50,000,000 from Cathay Capital, Sofinnova Partners, featuring lead investors Cathay Capital. About the […]
Grant – TumorGen
On Aug 26, 2021 TumorGen closed a Grant round and raised $390,000 from National Cancer Institute, featuring lead investors National Cancer Institute. About the company: […]
Seed Round – Kintsugi
On Aug 26, 2021 Kintsugi closed a Seed round and raised $8,000,000 from Acrew Capital, Adam Grosser, Darling Ventures, Eric Yuan, On Deck, Techstars, featuring […]
Series B – Neurogastrx
On Aug 26, 2021 Neurogastrx closed a Series B round and raised $60,000,000 from 5AM Ventures, Marshall Wace, OrbiMed, RTW Investments LLC, Samsara BioCapital, venBio […]
Series B – Neurogastrx
On Aug 26, 2021 Neurogastrx closed a Series B round and raised $60,000,000 from 5AM Ventures, Marshall Wace, OrbiMed, RTW Investments LLC, Samsara BioCapital, venBio […]
Series A – Nutromics
On Aug 27, 2021 Nutromics closed a Series A round and raised A$5,700,000 from Artesian VC, featuring lead investors . About the company: Nutromics is […]
Series A – Nutromics
On Aug 27, 2021 Nutromics closed a Series A round and raised A$5,700,000 from Artesian VC, featuring lead investors . About the company: Nutromics is […]
Series B – Cardior Pharmaceuticals
On Aug 25, 2021 Cardior Pharmaceuticals closed a Series B round and raised €64,000,000 from BioMedPartners, Bristol Myers Squibb, coparion, Fund+, Hadean Ventures, High-Tech Grunderfonds, […]
Series B – Cardior Pharmaceuticals
On Aug 25, 2021 Cardior Pharmaceuticals closed a Series B round and raised €64,000,000 from BioMedPartners, Bristol Myers Squibb, coparion, Fund+, Hadean Ventures, High-Tech Grunderfonds, […]